Revised forecast
Fiscal year ending February 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Impairment loss: ¥29 million; valuation loss on investment securities: ¥3 million; provision for losses on liquidation of affiliated companies: ¥61 million; total extraordinary losses: ¥92 million
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥37,000 million |
| Operating profit | Not disclosed → ¥2,400 million |
| Ordinary income | Not disclosed → ¥2,700 million |
| Profit attributable to owners of the parent | Not disclosed → ¥1,550 million |
| Net income per share | Not disclosed → 168.9 yen |
| Fiscal Period Covered | Fiscal year ending February 2027 |
| Period Covered | Full year |
| Previous-period results | Net sales: ¥34,871 million; operating profit: ¥2,367 million; ordinary profit: ¥2,704 million; profit attributable to owners of the parent: ¥1,525 million; basic earnings per share: ¥166.23 |
| Details and amount of extraordinary loss | Impairment loss: ¥29 million; valuation loss on investment securities: ¥3 million; provision for losses on liquidation of affiliated companies: ¥61 million; total extraordinary losses: ¥92 million |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the fiscal year ended February 2026, operating profit increased due to higher sales of high-value-added products and tight control of selling, general and administrative expenses. Looking ahead, the company cites expected growth in IT investment and fiscal expansion and AI investment in major countries, while also identifying U.S. tariff measures, an economic slowdown in China, fluctuations in foreign exchange rates and crude oil prices, and geopolitical risks as factors to monitor.